60 research outputs found
Prenatal Exposure to Polycyclic Aromatic Hydrocarbons, Benzo[a]pyrene–DNA Adducts, and Genomic DNA Methylation in Cord Blood
Background: Polycyclic aromatic hydrocarbons (PAHs) are carcinogenic environmental pollutants generated during incomplete combustion. After exposure and during metabolism, PAHs can form reactive epoxides that can covalently bind to DNA. These PAH–DNA adducts are established markers of cancer risk. PAH exposure has been associated with epigenetic alterations, including genomic cytosine methylation. Both global hypomethylation and hypermethylation of specific genes have been associated with cancer and other diseases in humans. Experimental evidence suggests that PAH–DNA adduct formation may preferentially target methylated genomic regions. Early embryonic development may be a particularly susceptible period for PAH exposure, resulting in both increased PAH–DNA adducts and altered DNA methylation
C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum—a single center pilot study
Alteration of enzymatic DNA methylation: A possible mechanism involved in the initiation of chemical carcinogenesis
Reevaluation of C-Reactive Protein in Cancer Sera by Radioimmunoassay and Radial Immunodiffusion
C-Peptide, Testosterone, Estrogen, Cortisol and Zinc in Patients with Benign Hyperplasia of the Prostate
Identification of Proliferatively Active Cells by Monoclonal Antibodies Against Dna-Cytosine-5 Methyltransferase
Elevated level of enzymatic dna methylation in cells treated with 1-beta-d-arabinofuranosylcytosine.
Effect of carcinogen ethionine on enzymatic methylation of dna sequences with various degrees of repetitiveness.
- …
